185 related articles for article (PubMed ID: 33849574)
1. Evaluation of functional status among patients undergoing maintenance treatments for opioid use disorders.
Ruíz Ruíz JJ; Martinez Delgado JM; García-Marchena N;
Harm Reduct J; 2021 Apr; 18(1):41. PubMed ID: 33849574
[TBL] [Abstract][Full Text] [Related]
2. Frequency and correlates of sleep disturbance in methadone and buprenorphine-maintained patients.
Dunn KE; Finan PH; Andrew Tompkins D; Strain EC
Addict Behav; 2018 Jan; 76():8-14. PubMed ID: 28735039
[TBL] [Abstract][Full Text] [Related]
3. Non-prescribed use of methadone and buprenorphine prior to opioid substitution treatment: lifetime prevalence, motives, and drug sources among people with opioid dependence in five Swedish cities.
Johnson B; Richert T
Harm Reduct J; 2019 May; 16(1):31. PubMed ID: 31046774
[TBL] [Abstract][Full Text] [Related]
4. The prevalence of sexual dysfunction among male patients on methadone and buprenorphine treatments: a meta-analysis study.
Yee A; Loh HS; Hisham Hashim HM; Ng CG
J Sex Med; 2014 Jan; 11(1):22-32. PubMed ID: 24344738
[TBL] [Abstract][Full Text] [Related]
5. Clinical factors associated with sexual dysfunction among men in methadone maintenance treatment and buprenorphine maintenance treatment: a meta-analysis study.
Yee A; Loh HS; Hisham Hashim HM; Ng CG
Int J Impot Res; 2014; 26(5):161-6. PubMed ID: 24990199
[TBL] [Abstract][Full Text] [Related]
6. Hepatitis C virus infection and pain sensitivity in patients on methadone or buprenorphine maintenance therapy for opioid use disorders.
Tsui JI; Lira MC; Cheng DM; Winter MR; Alford DP; Liebschutz JM; Mao J; Edwards RR; Samet JH
Drug Alcohol Depend; 2015 Aug; 153():286-92. PubMed ID: 26048638
[TBL] [Abstract][Full Text] [Related]
7. A comparison of characteristics and outcomes of opioid-dependent patients initiating office-based buprenorphine or methadone maintenance treatment.
Fingerhood MI; King VL; Brooner RK; Rastegar DA
Subst Abus; 2014; 35(2):122-6. PubMed ID: 24821346
[TBL] [Abstract][Full Text] [Related]
8. Sexual Dysfunction in Heroin Dependents: A Comparison between Methadone and Buprenorphine Maintenance Treatment.
Yee A; Danaee M; Loh HS; Sulaiman AH; Ng CG
PLoS One; 2016; 11(1):e0147852. PubMed ID: 26820154
[TBL] [Abstract][Full Text] [Related]
9. Plasma Testosterone and Sexual Function in Southeast Asian Men Receiving Methadone and Buprenorphine Maintenance Treatment.
Yee A; Loh HS; Danaee M; Riahi S; Ng CG; Sulaiman AH
J Sex Med; 2018 Feb; 15(2):159-166. PubMed ID: 29275046
[TBL] [Abstract][Full Text] [Related]
10. Outcome evaluation of the opioid agonist maintenance treatment in Iran.
Esmaeili HR; Ziaddinni H; Nikravesh MR; Baneshi MR; Nakhaee N
Drug Alcohol Rev; 2014 Mar; 33(2):186-93. PubMed ID: 24428135
[TBL] [Abstract][Full Text] [Related]
11. Methadone and buprenorphine-naloxone are effective in reducing illicit buprenorphine and other opioid use, and reducing HIV risk behavior--outcomes of a randomized trial.
Otiashvili D; Piralishvili G; Sikharulidze Z; Kamkamidze G; Poole S; Woody GE
Drug Alcohol Depend; 2013 Dec; 133(2):376-82. PubMed ID: 23916321
[TBL] [Abstract][Full Text] [Related]
12. Design considerations for point-of-care clinical trials comparing methadone and buprenorphine treatment for opioid dependence in pregnancy and for neonatal abstinence syndrome.
Winhusen T; Wilder C; Wexelblatt SL; Theobald J; Hall ES; Lewis D; Van Hook J; Marcotte M
Contemp Clin Trials; 2014 Sep; 39(1):158-65. PubMed ID: 25183042
[TBL] [Abstract][Full Text] [Related]
13. Utilization of buprenorphine and methadone among opioid users who inject drugs.
Tsui JI; Burt R; Thiede H; Glick SN
Subst Abus; 2018 Jan; 39(1):83-88. PubMed ID: 28796591
[TBL] [Abstract][Full Text] [Related]
14. Alcohol use disorders in opioid maintenance therapy: prevalence, clinical correlates and treatment.
Soyka M
Eur Addict Res; 2015; 21(2):78-87. PubMed ID: 25413371
[TBL] [Abstract][Full Text] [Related]
15. Six-Year Outcome of Opioid Maintenance Treatment in Heroin-Dependent Patients: Results from a Naturalistic Study in a Nationally Representative Sample.
Soyka M; Strehle J; Rehm J; Bühringer G; Wittchen HU
Eur Addict Res; 2017; 23(2):97-105. PubMed ID: 28376505
[TBL] [Abstract][Full Text] [Related]
16. Buprenorphine/naloxone versus methadone in opioid dependence: a longitudinal survey.
Curcio F; Franco T; Topa M; Baldassarre C;
Eur Rev Med Pharmacol Sci; 2011 Aug; 15(8):871-4. PubMed ID: 21845796
[TBL] [Abstract][Full Text] [Related]
17. Delayed villous maturation in term placentas exposed to opioid maintenance therapy: a retrospective cohort study.
Serra AE; Lemon LS; Mokhtari NB; Parks WT; Catov JM; Venkataramanan R; Caritis SN
Am J Obstet Gynecol; 2017 Apr; 216(4):418.e1-418.e5. PubMed ID: 28024988
[TBL] [Abstract][Full Text] [Related]
18. Opioid use disorder in Germany: healthcare costs of patients in opioid maintenance treatment.
Reimer J; Vogelmann T; Trümper D; Scherbaum N
Subst Abuse Treat Prev Policy; 2019 Dec; 14(1):57. PubMed ID: 31842942
[TBL] [Abstract][Full Text] [Related]
19. Patterns of physician prescribing for opioid maintenance treatment in Ontario, Canada in 2014.
Guan Q; Khuu W; Spithoff S; Kiran T; Kahan M; Tadrous M; Martins D; Leece P; Gomes T
Drug Alcohol Depend; 2017 Aug; 177():315-321. PubMed ID: 28733101
[TBL] [Abstract][Full Text] [Related]
20. A longitudinal comparison of retention in buprenorphine and methadone treatment for opioid dependence in New South Wales, Australia.
Burns L; Gisev N; Larney S; Dobbins T; Gibson A; Kimber J; Larance B; Mattick RP; Butler T; Degenhardt L
Addiction; 2015 Apr; 110(4):646-55. PubMed ID: 25516077
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
